Team:Tufts/Project

From 2014.igem.org

(Difference between revisions)
Line 75: Line 75:
<tr>
<tr>
<td width="45%"  valign="top">  
<td width="45%"  valign="top">  
 +
<p> Ribosponge Project Description:
 +
 +
We have devised a method to introduce a DNA sequence which encodes an RNA aptamer (i.e. - an
 +
 +
oligonucleotide sequence which binds to a specific molecule) into a non-pathogenic E. coli strain. We
 +
 +
have dubbed this RNA aptamer a “ribosponge” due to its unique mode of action. The ribosponge binds
 +
 +
cyclic di-GMP, a secondary intracellular messenger which signals bacteria to enter a persistent or biofilm
 +
 +
state. The signal is universal among many species such as E. coli, P. aeruginosa, and M. tuberculosis.
 +
 +
Blocking the signal of c-di-GMP by binding it with an aptamer could prevent the persistent state in these
 +
 +
and other pathogens. In order to ferry the sequence encoding the aptamer from our non-pathogenic E.
 +
 +
coli into other bacteria of the same species, we plan on using an M13 phage which does not kill the
 +
 +
bacteria.
 +
 +
The project has also inspired our collaboration with the Rathneau Institute and SYNENERGENE as we
 +
 +
look at the feasability of developing ribosponge into a product, and examine the regulatory, legal, and
 +
 +
ethical challenges of packing it into a bacteriophage.</p>
 +
<p>Tell us more about your project.  Give us background.  Use this as the abstract of your project.  Be descriptive but concise (1-2 paragraphs) </p>
<p>Tell us more about your project.  Give us background.  Use this as the abstract of your project.  Be descriptive but concise (1-2 paragraphs) </p>
<br>
<br>

Revision as of 18:02, 15 August 2014

Tufts iGEM 2014

Click here to edit this page!

Home Team Official Team Profile Project Parts Modeling Notebook Safety Attributions

Project Description

Content

Ribosponge Project Description: We have devised a method to introduce a DNA sequence which encodes an RNA aptamer (i.e. - an oligonucleotide sequence which binds to a specific molecule) into a non-pathogenic E. coli strain. We have dubbed this RNA aptamer a “ribosponge” due to its unique mode of action. The ribosponge binds cyclic di-GMP, a secondary intracellular messenger which signals bacteria to enter a persistent or biofilm state. The signal is universal among many species such as E. coli, P. aeruginosa, and M. tuberculosis. Blocking the signal of c-di-GMP by binding it with an aptamer could prevent the persistent state in these and other pathogens. In order to ferry the sequence encoding the aptamer from our non-pathogenic E. coli into other bacteria of the same species, we plan on using an M13 phage which does not kill the bacteria. The project has also inspired our collaboration with the Rathneau Institute and SYNENERGENE as we look at the feasability of developing ribosponge into a product, and examine the regulatory, legal, and ethical challenges of packing it into a bacteriophage.

Tell us more about your project. Give us background. Use this as the abstract of your project. Be descriptive but concise (1-2 paragraphs)


References

iGEM teams are encouraged to record references you use during the course of your research. They should be posted somewhere on your wiki so that judges and other visitors can see how you though about your project and what works inspired you.

You can use these subtopics to further explain your project

  1. Overall project summary
  2. Project Details
  3. Materials and Methods
  4. The Experiments
  5. Results
  6. Data analysis
  7. Conclusions

It's important for teams to describe all the creativity that goes into an iGEM project, along with all the great ideas your team will come up with over the course of your work.

It's also important to clearly describe your achievements so that judges will know what you tried to do and where you succeeded. Please write your project page such that what you achieved is easy to distinguish from what you attempted.